// App-Quantinova.ai

1016 : Anthracycline-induced cardiotoxicity in patients with early stage breast cancer: The Canadian cancer trials group (NCIC CTG) MA.21 experience.

Researchers

Presenter

  • Susan Faye Dent

Principal Investigators

  • Olexiy Aseyev

  • Mark Norman Levine

  • Kathleen I. Pritchard

  • Wendy R. Parulekar

  • Bingshu E. Chen

  • Patti O'Brien

  • Margot J. Burnell

  • Lois E. Shepherd

Medical Centers

  • Ottawa Hospital Cancer Centre, Ottawa, ON, Canada

  • Ottawa Hospital Cancer Center, University of Ottawa, Ottawa, ON, Canada

  • McMaster University, Hamilton, ON, Canada

  • Sunnybrook Odette Cancer Centre, Toronto, ON, Canada

  • NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Kingston, ON, Canada

  • Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada

  • NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Kingston, ON, Canada

  • Saint John Regional Hospital, Saint John, NB, Canada

  • Canadian Cancer Trials Group, Kingston, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Left ventricular dysfunction

  • Breast cancer

  • Congestive heart failure

  • Cardiotoxicity

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • NCT00014222

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved